Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Michael Simons, Nicolas A.F. Chronos, Timothy D. Henry et al.|Circulation|2002Cited by 652
Pharmacokinetics and Pharmacodynamics of Recombinant FGF‐2 in a Phase I Trial in Coronary Artery DiseaseMark Bush, Nicolas A.F. Chronos, Emil Samara et al.|The Journal of Clinical Pharmacology|2001Cited by 48